Abnova Taiwan Corp Stock Current Valuation
| 4133 Stock | TWD 29.10 0.05 0.17% |
Valuation analysis of Abnova Taiwan Corp helps investors to measure Abnova Taiwan's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Abnova Taiwan's price fluctuation is very steady at this time. Calculation of the real value of Abnova Taiwan Corp is based on 3 months time horizon. Increasing Abnova Taiwan's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Abnova stock is determined by what a typical buyer is willing to pay for full or partial control of Abnova Taiwan Corp. Since Abnova Taiwan is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Abnova Stock. However, Abnova Taiwan's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 29.1 | Real 29.59 | Hype 29.1 |
The intrinsic value of Abnova Taiwan's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Abnova Taiwan's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Abnova Taiwan Corp helps investors to forecast how Abnova stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Abnova Taiwan more accurately as focusing exclusively on Abnova Taiwan's fundamentals will not take into account other important factors: Abnova Taiwan Corp Company Current Valuation Analysis
Abnova Taiwan's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Abnova Taiwan Current Valuation | 2.11 B |
Most of Abnova Taiwan's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abnova Taiwan Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Abnova Taiwan Corp has a Current Valuation of 2.11 B. This is 85.33% lower than that of the Life Sciences Tools & Services sector and 54.65% lower than that of the Health Care industry. The current valuation for all Taiwan stocks is 87.33% higher than that of the company.
Abnova Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abnova Taiwan's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abnova Taiwan could also be used in its relative valuation, which is a method of valuing Abnova Taiwan by comparing valuation metrics of similar companies.Abnova Taiwan is currently under evaluation in current valuation category among its peers.
Abnova Fundamentals
| Return On Equity | 0.0505 | |||
| Return On Asset | 0.0227 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 2.11 B | |||
| Shares Outstanding | 60.55 M | |||
| Shares Owned By Insiders | 22.37 % | |||
| Shares Owned By Institutions | 0.55 % | |||
| Price To Earning | 64.88 X | |||
| Price To Book | 1.98 X | |||
| Price To Sales | 5.86 X | |||
| Revenue | 451.49 M | |||
| Gross Profit | 197.34 M | |||
| EBITDA | 78.59 M | |||
| Net Income | 28.37 M | |||
| Cash And Equivalents | 171.86 M | |||
| Cash Per Share | 2.84 X | |||
| Total Debt | 18.4 M | |||
| Debt To Equity | 1.50 % | |||
| Current Ratio | 7.87 X | |||
| Book Value Per Share | 20.50 X | |||
| Cash Flow From Operations | 92.88 M | |||
| Earnings Per Share | 1.02 X | |||
| Target Price | 102.08 | |||
| Number Of Employees | 14 | |||
| Beta | 0.42 | |||
| Market Capitalization | 2.3 B | |||
| Total Asset | 1.28 B | |||
| Retained Earnings | 92 M | |||
| Working Capital | 849 M | |||
| Current Asset | 956 M | |||
| Current Liabilities | 107 M | |||
| Z Score | 75.0 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 2.32 % | |||
| Net Asset | 1.28 B | |||
| Last Dividend Paid | 0.46 |
About Abnova Taiwan Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abnova Taiwan Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abnova Taiwan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abnova Taiwan Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Abnova Stock Analysis
When running Abnova Taiwan's price analysis, check to measure Abnova Taiwan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abnova Taiwan is operating at the current time. Most of Abnova Taiwan's value examination focuses on studying past and present price action to predict the probability of Abnova Taiwan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abnova Taiwan's price. Additionally, you may evaluate how the addition of Abnova Taiwan to your portfolios can decrease your overall portfolio volatility.